YTRA: Turning the Corner as Travel Slowly Resumes after Second Wave of COVID-19 Subsides & Vaccinations Pick Up
By TIm Moore, CFA
NASDAQ:YTRA
READ THE FULL YTRA RESEARCH REPORT
TNXP: Multiple COVID Programs and Building Domestic Vaccine Research Infrastructure…
By David Bautz, PhD
NASDAQ:TNXP
READ THE FULL TNXP RESEARCH REPORT
DFFN: Initial Indication for TSC to be Announced 4Q21…
By David Bautz, PhD
NASDAQ:DFFN
READ THE FULL DFFN RESEARCH REPORT
SNGX: Positive Preclinical Data for Filovirus Vaccine Candidates…
By David Bautz, PhD
NASDAQ:SNGX
READ THE FULL SNGX RESEARCH REPORT
VNRX: Revenues from Nu.Q Vet Cancer Screening Test steady from beta test; Silver One expected to generate revenues in late 2021.
By Steven Ralston, CFA
NYSE:VNRX
READ THE FULL VNRX RESEARCH REPORT
VNRX: Revenues from Nu.Q Vet Cancer Screening Test steady from beta test; Silver One expected to generate revenues in late 2021.
By Steven Ralston, CFA
NYSE:VNRX
READ THE FULL VNRX RESEARCH REPORT
MDNA: On Track to Dose First Patient in MDNA11 Phase 1 Trial in 3Q21…
By David Bautz, PhD
NASDAQ:MDNA
READ THE FULL MDNA RESEARCH REPORT
DRIO: Dario’s RPM Accelerating
By John Vandermosten, CFA
NASDAQ:DRIO
READ THE FULL DRIO RESEARCH REPORT
PLX: Debt Maturities Resolved
By John Vandermosten, CFA
NYSE:PLX
READ THE FULL PLX RESEARCH REPORT
LGIQ: Revenues and Margins Improve Sequentially Again in Q2 2021
By Lisa Thompson
OTC:LGIQ
READ THE FULL LGIQ RESEARCH REPORT